https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/us-fda-approves-precigens-immunotherapy-for-rare-respiratory-disease/123331133
FDA Approval: US FDA approves Precigen's immunotherapy for rare respiratory disease, ETPharma
FDA Approval: The approval was based on an early-to-mid-stage study data that showed 51 per cent of patients required no surgeries in the 12 months after the...
fda approvalrare respiratoryusapprovesimmunotherapy
https://www.mdpi.com/2077-0383/10/6/1268
Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases
Several studies have shown that some rare respiratory diseases, such as alpha-1 antitrypsin deficiency (AATD), idiopathic pulmonary fibrosis (IPF), cystic...
oxidative stressendoplasmic reticulumrare respiratorydiseases